Inflammatory and Tissue Damage Biomarkers Progression as Mortality Prognosis in Patients with Covid-۱۹ Disease

  • سال انتشار: 1400
  • محل انتشار: مجله پزشکی قلب و قفسه سینه، دوره: 9، شماره: 4
  • کد COI اختصاصی: JR_JCTM-9-4_002
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 156
دانلود فایل این مقاله

نویسندگان

Monica Escamilla Tilch

Science Research Doctor, Biomedical Research Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Lourdes López Dawn

Cardiothoracic Surgeon, Cardiovascular Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Adriana Balderrama

Endocrinologist, Endocrinology Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Francisco Ramírez Bernal

Intensive Care Physician, Intensive Therapy Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Brigney Aceves Poveda

Intensive Care Physician, Intensive Therapy Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Guillermo Díaz Quiroz

Cardiothoracic Surgeon, Cardiovascular Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Alberto De la Vega

Intensive Care Physician, Intensive Therapy Department, CMN ۲۰ de Noviembre ISSSTE, México City.

Paul Mondragón-Terán

Bio-medical Engineer, Research Coordination, CMN ۲۰ de Noviembre ISSSTE, México City.

José Aceves Chimal

Cardiothoracic Surgeon, Cardiovascular Department, CMN ۲۰ de Noviembre ISSSTE, México City.

چکیده

Introduction: Metabolic and inflammatory disorders are widely described in COVID-۱۹ disease by SARS-CoV-۲, especially in advanced gravity stages, nevertheless, the increase in inflammatory and tissue damage biomarkers could identify patients with higher mortality risk since early disease stages.Material and Method: A retrospective Cohort study was performed to evaluate the progression pattern and mortality risk of proinflammatory (Ferritin and IL-۶) and damage tissue biomarkers seric levels (LDH, CPK, CPK-MB and TnIc) since the beginning of the disease to end outcome considered, in this study, as death or recoveryResults: We evaluated ۱۲۰ patients with mean age ۵۱±۱۰ years. The CAT study showed in all patients bilateral polished glass lung lesions. The inflammatory and seric tissue injured biomarkers were significantly higher since the beginning of the hospitalization in patients who died compared with patients that survived (p = ۰.۰۱). The myocardial injury biomarkers (CPK-MB and TnIc) were significantly higher in severe gravity stages of deceased patients compared to patients who survived (p = ۰.۰۰۱ and ۰.۰۰۳ respectively) with a global mortality of ۳۸.۳% (n = ۴۸). The mortality risk was extremely elevated (RR> ۱۰) when inflammatory and tissue injury biomarkers showed seric levels ۲ folds above normal values, showing survival of  < ۶۰% after tenth day since the beginning disease.Conclusion: Since the beginning of COVID-۱۹ disease by SARS CoV۲ virus, patients show serum elevation in ferritin, LDH and CPK. This seric values were associated with higher mortality risk, when elevated ۲ folds above normal values.

کلیدواژه ها

SARS-CoV-۲, COVID-۱۹, inflammatory Biomarkers, Tissue injury

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.